Related Experiment Video
Updated: May 21, 2025
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
660
Pulmonology: What You May Have Missed in 2024.
Namarik Alenezy1, Yusing Gu1, Rana Saleh1
1McMaster University, Hamilton, Ontario, Canada (N.A., Y.G., R.S., L.S.).
Annals of Internal Medicine
|March 31, 2025
Summary
This review highlights 10 key 2024 pulmonology publications, focusing on advanced COPD and asthma management, obstructive sleep apnea treatments, and influenza prevention strategies.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Critical Care
Background:
- Pulmonology research in 2024 yielded significant advancements in managing diverse respiratory conditions.
- Over 750 articles were screened, with 10 selected for their impact on patient care.
Purpose of the Study:
- To summarize pivotal 2024 publications in pulmonology.
- To highlight novel therapeutic strategies and evidence-based guidelines for respiratory diseases.
Main Methods:
- Systematic screening of over 750 pulmonology articles published in 2024.
- Selection of 10 high-impact studies covering chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea, bronchiectasis, and influenza.
Main Results:
- Exploration of non-pharmacological COPD management, including breathing techniques and ventilation strategies.
- Review of biologic therapies and inhaled relievers for asthma, plus a trial on benralizumab for exacerbations.
- Investigation into novel treatments for obstructive sleep apnea and the efficacy of inhaled antibiotics for bronchiectasis.
- Analysis of antiviral prophylaxis for influenza.
Conclusions:
- Recent pulmonology literature offers expanded therapeutic options beyond pharmacotherapy for COPD and asthma.
- Emerging treatments show promise for obstructive sleep apnea and bronchiectasis.
- Evidence supports antiviral prophylaxis in managing influenza.
Related Concept Videos
01:17Other Pulmonary Disorders
789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789
01:20COPD: Pathogenesis and Clinical Features
219
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
219
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:28Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
01:30Pulmonary Hypertension: Classification and Pathogenesis
139
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
139